Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: A case-control study

Allergy and Asthma Proceedings

Volumn 33, Issue 2, 2012, Pages

  Joshi, Avni Y ^a   Iyer, Vivek N ^a   Hartz, Martha F ^a   Patel, Ashok M ^a   Li, James T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; VACCINATION; VIRUS ISOLATION;

ADOLESCENT; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRAMUSCULAR; ODDS RATIO; TREATMENT OUTCOME; VACCINATION; VACCINES, INACTIVATED;

EID: 84860238466     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3513     Document Type: Article

References (18)

1. Glezen WP. Influenza vaccination for healthy children. Curr Opin Infect Dis 15:283-287, 2002. (Pubitemid 34548191)
2. Monto AS. Epidemiology of viral respiratory infections. Am J Med 112(suppl 6A):4S-12S, 2002. (Pubitemid 34304336)
3. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1-54, 2007.
4. Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 194:1032-1039, 2006. (Pubitemid 44547642)
5. Joshi AY, Iyer VN, St Sauver JL, et al. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case-control study. Vaccine 27:4457-4461, 2009.
6. Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 185(suppl):S48-S53, 2006. (Pubitemid 44823407)
7. Centers for Disease Control and Prevention: Past Weekly Surveillance Reports. Available online at http://www.cdc.gov/flu/weekly/pastreports.htm; last accessed March 20, 2012.
8. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25:860-869, 2006. (Pubitemid 44510577)
9. Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J 25:870-879, 2006. (Pubitemid 44510578)
10. Halloran ME, Piedra PA, Longini IM, Jr., et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 25:4038-4045, 2007. (Pubitemid 46628989)
11. Tam JS, Capeding MR, Lum LC, et al. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J 26:619-628, 2007. (Pubitemid 47014164)
12. Vesikari T, Fleming DM, Aristegui JF, et al. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care. Pediatrics 118:2298 -2312, 2006.
13. Gaglani MJ, Piedra PA, Riggs M, et al. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr Infect Dis J 27:444-452, 2008.
14. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 116:e397-e407, 2005. (Pubitemid 44339432)
15. Vesikari T. Emerging data on the safety and efficacy of influenza vaccines in children. Pediatr Infect Dis J 27(suppl):S159-S161 2008.
16. Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 25;860-869, 2006 (Pubitemid 44510577)
17. Sackett DL. Bias in analytic research. J Chronic Dis 32:51-63, 1979.
18. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 71:266-274, 1996.